Global Ovarian Cancer Targeted Therapy Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Ovarian cancer is the most common cause of mortality for women with gynecological cancers Additionally, it ranks as the seventh most common cause of mortality for females overall. The majority of instances are discovered when the disease has already progressed, which leads to poor outcomes. The cancer cells can be marked with a specific targeted therapy, making it simpler for the immune system to recognize and eliminate them. In addition, some targeted therapies can help in enhancing the immune system so that it fights cancer effectively which further boost the market growth.
The global Ovarian Cancer Targeted Therapy Drugs market size is projected to grow from US$ 1783 million in 2024 to US$ 2978 million in 2030; it is expected to grow at a CAGR of 8.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Ovarian Cancer Targeted Therapy Drugs Industry Forecast” looks at past sales and reviews total world Ovarian Cancer Targeted Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Ovarian Cancer Targeted Therapy Drugs sales for 2023 through 2029. With Ovarian Cancer Targeted Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ovarian Cancer Targeted Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Ovarian Cancer Targeted Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ovarian Cancer Targeted Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ovarian Cancer Targeted Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ovarian Cancer Targeted Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ovarian Cancer Targeted Therapy Drugs.
Asia-Pacific expected to grow at the highest rate during the ovarian cancer drugs market forecast. The market growth in this region is attributable to presence of pharmaceutical companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, rise in personalized medicine expenditure and adoption of high-tech processing to improve the production of ovarian cancer drugs, drive the growth of the market. In addition, high population base, presence of unmet medical needs, and increase in disposable incomes of people in the region further boost the market growth. Moreover, rise in medical tourism and developing healthcare infrastructure make Asia-Pacific a lucrative market for ovarian cancer drugs.Furthermore, increase in technological innovations in drug discovery, surge in funding provided by the government and private organizations, presence of large number of healthcare reforms, and increase in aging population of woman drive the growth of the market. Moreover, increase in demand for advanced healthcare services in emerging economies such as India and China are the major factors that drive the growth of the Asia-Pacific market. Asia-Pacific offers profitable opportunities for key players operating in the ovarian cancer drugs market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as well-established presence of domestic companies in the region. In addition, rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region.
This report presents a comprehensive overview, market shares, and growth opportunities of Ovarian Cancer Targeted Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Ovarian cancer is the most common cause of mortality for women with gynecological cancers Additionally, it ranks as the seventh most common cause of mortality for females overall. The majority of instances are discovered when the disease has already progressed, which leads to poor outcomes. The cancer cells can be marked with a specific targeted therapy, making it simpler for the immune system to recognize and eliminate them. In addition, some targeted therapies can help in enhancing the immune system so that it fights cancer effectively which further boost the market growth.
The global Ovarian Cancer Targeted Therapy Drugs market size is projected to grow from US$ 1783 million in 2024 to US$ 2978 million in 2030; it is expected to grow at a CAGR of 8.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Ovarian Cancer Targeted Therapy Drugs Industry Forecast” looks at past sales and reviews total world Ovarian Cancer Targeted Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Ovarian Cancer Targeted Therapy Drugs sales for 2023 through 2029. With Ovarian Cancer Targeted Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ovarian Cancer Targeted Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Ovarian Cancer Targeted Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ovarian Cancer Targeted Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ovarian Cancer Targeted Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ovarian Cancer Targeted Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ovarian Cancer Targeted Therapy Drugs.
Asia-Pacific expected to grow at the highest rate during the ovarian cancer drugs market forecast. The market growth in this region is attributable to presence of pharmaceutical companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, rise in personalized medicine expenditure and adoption of high-tech processing to improve the production of ovarian cancer drugs, drive the growth of the market. In addition, high population base, presence of unmet medical needs, and increase in disposable incomes of people in the region further boost the market growth. Moreover, rise in medical tourism and developing healthcare infrastructure make Asia-Pacific a lucrative market for ovarian cancer drugs.Furthermore, increase in technological innovations in drug discovery, surge in funding provided by the government and private organizations, presence of large number of healthcare reforms, and increase in aging population of woman drive the growth of the market. Moreover, increase in demand for advanced healthcare services in emerging economies such as India and China are the major factors that drive the growth of the Asia-Pacific market. Asia-Pacific offers profitable opportunities for key players operating in the ovarian cancer drugs market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as well-established presence of domestic companies in the region. In addition, rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region.
This report presents a comprehensive overview, market shares, and growth opportunities of Ovarian Cancer Targeted Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- PARP Inhibitors
- Angiogenesis Inhibitors
- Others
- Hospital Pharmacy
- Drug Stores and Retail Pharmacy
- Online Providers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PARP Inhibitors
- Angiogenesis Inhibitors
- Others
- Hospital Pharmacy
- Drug Stores and Retail Pharmacy
- Online Providers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck KGaA
- GlaxoSmithKline plc
- Johnson & Johnson Services, Inc
- F. Hoffmann-La Roche AG
- Boehringer Ingelheim International GmbH
- Abbvie Inc
- AstraZeneca
- Pfizer, Inc
- Clovis Oncology
- Amgen Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2030
2.1.2 Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Ovarian Cancer Targeted Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Ovarian Cancer Targeted Therapy Drugs Segment by Type
2.2.1 PARP Inhibitors
2.2.2 Angiogenesis Inhibitors
2.2.3 Others
2.3 Ovarian Cancer Targeted Therapy Drugs Market Size by Type
2.3.1 Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Ovarian Cancer Targeted Therapy Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Drug Stores and Retail Pharmacy
2.4.3 Online Providers
2.5 Ovarian Cancer Targeted Therapy Drugs Market Size by Application
2.5.1 Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
3 OVARIAN CANCER TARGETED THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Player
3.1.1 Global Ovarian Cancer Targeted Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Ovarian Cancer Targeted Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OVARIAN CANCER TARGETED THERAPY DRUGS BY REGION
4.1 Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024)
4.2 Global Ovarian Cancer Targeted Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OVARIAN CANCER TARGETED THERAPY DRUGS MARKET FORECAST
10.1 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas Ovarian Cancer Targeted Therapy Drugs Forecast
10.1.3 APAC Ovarian Cancer Targeted Therapy Drugs Forecast
10.1.4 Europe Ovarian Cancer Targeted Therapy Drugs Forecast
10.1.5 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Forecast
10.2 Americas Ovarian Cancer Targeted Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.2.2 Canada Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.2.3 Mexico Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.2.4 Brazil Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3 APAC Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Ovarian Cancer Targeted Therapy Drugs Market Forecast
10.3.2 Japan Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.3 Korea Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.4 Southeast Asia Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.5 India Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.6 Australia Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4 Europe Ovarian Cancer Targeted Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.2 France Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.3 UK Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.4 Italy Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.5 Russia Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5.2 South Africa Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5.3 Israel Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5.4 Turkey Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.6 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Ovarian Cancer Targeted Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck KGaA
11.1.1 Merck KGaA Company Information
11.1.2 Merck KGaA Ovarian Cancer Targeted Therapy Drugs Product Offered
11.1.3 Merck KGaA Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck KGaA Main Business Overview
11.1.5 Merck KGaA Latest Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Information
11.2.2 GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.2.3 GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline plc Main Business Overview
11.2.5 GlaxoSmithKline plc Latest Developments
11.3 Johnson & Johnson Services, Inc
11.3.1 Johnson & Johnson Services, Inc Company Information
11.3.2 Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.3.3 Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Services, Inc Main Business Overview
11.3.5 Johnson & Johnson Services, Inc Latest Developments
11.4 F. Hoffmann-La Roche AG
11.4.1 F. Hoffmann-La Roche AG Company Information
11.4.2 F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Product Offered
11.4.3 F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 F. Hoffmann-La Roche AG Main Business Overview
11.4.5 F. Hoffmann-La Roche AG Latest Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Boehringer Ingelheim International GmbH Company Information
11.5.2 Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Product Offered
11.5.3 Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim International GmbH Main Business Overview
11.5.5 Boehringer Ingelheim International GmbH Latest Developments
11.6 Abbvie Inc
11.6.1 Abbvie Inc Company Information
11.6.2 Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.6.3 Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbvie Inc Main Business Overview
11.6.5 Abbvie Inc Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Ovarian Cancer Targeted Therapy Drugs Product Offered
11.7.3 AstraZeneca Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer, Inc
11.8.1 Pfizer, Inc Company Information
11.8.2 Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.8.3 Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer, Inc Main Business Overview
11.8.5 Pfizer, Inc Latest Developments
11.9 Clovis Oncology
11.9.1 Clovis Oncology Company Information
11.9.2 Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Product Offered
11.9.3 Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Clovis Oncology Main Business Overview
11.9.5 Clovis Oncology Latest Developments
11.10 Amgen Inc.
11.10.1 Amgen Inc. Company Information
11.10.2 Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Product Offered
11.10.3 Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Amgen Inc. Main Business Overview
11.10.5 Amgen Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2030
2.1.2 Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Ovarian Cancer Targeted Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Ovarian Cancer Targeted Therapy Drugs Segment by Type
2.2.1 PARP Inhibitors
2.2.2 Angiogenesis Inhibitors
2.2.3 Others
2.3 Ovarian Cancer Targeted Therapy Drugs Market Size by Type
2.3.1 Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Ovarian Cancer Targeted Therapy Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Drug Stores and Retail Pharmacy
2.4.3 Online Providers
2.5 Ovarian Cancer Targeted Therapy Drugs Market Size by Application
2.5.1 Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
3 OVARIAN CANCER TARGETED THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Player
3.1.1 Global Ovarian Cancer Targeted Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Ovarian Cancer Targeted Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OVARIAN CANCER TARGETED THERAPY DRUGS BY REGION
4.1 Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024)
4.2 Global Ovarian Cancer Targeted Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OVARIAN CANCER TARGETED THERAPY DRUGS MARKET FORECAST
10.1 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas Ovarian Cancer Targeted Therapy Drugs Forecast
10.1.3 APAC Ovarian Cancer Targeted Therapy Drugs Forecast
10.1.4 Europe Ovarian Cancer Targeted Therapy Drugs Forecast
10.1.5 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Forecast
10.2 Americas Ovarian Cancer Targeted Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.2.2 Canada Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.2.3 Mexico Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.2.4 Brazil Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3 APAC Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Ovarian Cancer Targeted Therapy Drugs Market Forecast
10.3.2 Japan Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.3 Korea Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.4 Southeast Asia Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.5 India Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.3.6 Australia Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4 Europe Ovarian Cancer Targeted Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.2 France Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.3 UK Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.4 Italy Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.4.5 Russia Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5 Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5.2 South Africa Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5.3 Israel Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.5.4 Turkey Market Ovarian Cancer Targeted Therapy Drugs Forecast
10.6 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Ovarian Cancer Targeted Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Ovarian Cancer Targeted Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck KGaA
11.1.1 Merck KGaA Company Information
11.1.2 Merck KGaA Ovarian Cancer Targeted Therapy Drugs Product Offered
11.1.3 Merck KGaA Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck KGaA Main Business Overview
11.1.5 Merck KGaA Latest Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Information
11.2.2 GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.2.3 GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline plc Main Business Overview
11.2.5 GlaxoSmithKline plc Latest Developments
11.3 Johnson & Johnson Services, Inc
11.3.1 Johnson & Johnson Services, Inc Company Information
11.3.2 Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.3.3 Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Services, Inc Main Business Overview
11.3.5 Johnson & Johnson Services, Inc Latest Developments
11.4 F. Hoffmann-La Roche AG
11.4.1 F. Hoffmann-La Roche AG Company Information
11.4.2 F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Product Offered
11.4.3 F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 F. Hoffmann-La Roche AG Main Business Overview
11.4.5 F. Hoffmann-La Roche AG Latest Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Boehringer Ingelheim International GmbH Company Information
11.5.2 Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Product Offered
11.5.3 Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim International GmbH Main Business Overview
11.5.5 Boehringer Ingelheim International GmbH Latest Developments
11.6 Abbvie Inc
11.6.1 Abbvie Inc Company Information
11.6.2 Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.6.3 Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbvie Inc Main Business Overview
11.6.5 Abbvie Inc Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Ovarian Cancer Targeted Therapy Drugs Product Offered
11.7.3 AstraZeneca Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer, Inc
11.8.1 Pfizer, Inc Company Information
11.8.2 Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
11.8.3 Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer, Inc Main Business Overview
11.8.5 Pfizer, Inc Latest Developments
11.9 Clovis Oncology
11.9.1 Clovis Oncology Company Information
11.9.2 Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Product Offered
11.9.3 Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Clovis Oncology Main Business Overview
11.9.5 Clovis Oncology Latest Developments
11.10 Amgen Inc.
11.10.1 Amgen Inc. Company Information
11.10.2 Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Product Offered
11.10.3 Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Amgen Inc. Main Business Overview
11.10.5 Amgen Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Ovarian Cancer Targeted Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of PARP Inhibitors
Table 4. Major Players of Angiogenesis Inhibitors
Table 5. Major Players of Others
Table 6. Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 9. Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 12. Global Ovarian Cancer Targeted Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 14. Ovarian Cancer Targeted Therapy Drugs Key Players Head office and Products Offered
Table 15. Ovarian Cancer Targeted Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 20. Global Ovarian Cancer Targeted Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 24. Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 26. Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 28. APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 30. APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Ovarian Cancer Targeted Therapy Drugs
Table 40. Key Market Challenges & Risks of Ovarian Cancer Targeted Therapy Drugs
Table 41. Key Industry Trends of Ovarian Cancer Targeted Therapy Drugs
Table 42. Global Ovarian Cancer Targeted Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Ovarian Cancer Targeted Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Ovarian Cancer Targeted Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Merck KGaA Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 47. Merck KGaA Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 48. Merck KGaA Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Merck KGaA Main Business
Table 50. Merck KGaA Latest Developments
Table 51. GlaxoSmithKline plc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 52. GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 53. GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. GlaxoSmithKline plc Main Business
Table 55. GlaxoSmithKline plc Latest Developments
Table 56. Johnson & Johnson Services, Inc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 57. Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 58. Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Johnson & Johnson Services, Inc Main Business
Table 60. Johnson & Johnson Services, Inc Latest Developments
Table 61. F. Hoffmann-La Roche AG Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 63. F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. F. Hoffmann-La Roche AG Main Business
Table 65. F. Hoffmann-La Roche AG Latest Developments
Table 66. Boehringer Ingelheim International GmbH Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 67. Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 68. Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Boehringer Ingelheim International GmbH Main Business
Table 70. Boehringer Ingelheim International GmbH Latest Developments
Table 71. Abbvie Inc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 72. Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 73. Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Abbvie Inc Main Business
Table 75. Abbvie Inc Latest Developments
Table 76. AstraZeneca Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 77. AstraZeneca Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 78. AstraZeneca Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Latest Developments
Table 81. Pfizer, Inc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 82. Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 83. Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Pfizer, Inc Main Business
Table 85. Pfizer, Inc Latest Developments
Table 86. Clovis Oncology Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 87. Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 88. Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Clovis Oncology Main Business
Table 90. Clovis Oncology Latest Developments
Table 91. Amgen Inc. Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 92. Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 93. Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Amgen Inc. Main Business
Table 95. Amgen Inc. Latest Developments
Table 1. Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Ovarian Cancer Targeted Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of PARP Inhibitors
Table 4. Major Players of Angiogenesis Inhibitors
Table 5. Major Players of Others
Table 6. Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 9. Ovarian Cancer Targeted Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 12. Global Ovarian Cancer Targeted Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 14. Ovarian Cancer Targeted Therapy Drugs Key Players Head office and Products Offered
Table 15. Ovarian Cancer Targeted Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 20. Global Ovarian Cancer Targeted Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 24. Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 26. Americas Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 28. APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 30. APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Ovarian Cancer Targeted Therapy Drugs
Table 40. Key Market Challenges & Risks of Ovarian Cancer Targeted Therapy Drugs
Table 41. Key Industry Trends of Ovarian Cancer Targeted Therapy Drugs
Table 42. Global Ovarian Cancer Targeted Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Ovarian Cancer Targeted Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Ovarian Cancer Targeted Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Merck KGaA Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 47. Merck KGaA Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 48. Merck KGaA Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Merck KGaA Main Business
Table 50. Merck KGaA Latest Developments
Table 51. GlaxoSmithKline plc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 52. GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 53. GlaxoSmithKline plc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. GlaxoSmithKline plc Main Business
Table 55. GlaxoSmithKline plc Latest Developments
Table 56. Johnson & Johnson Services, Inc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 57. Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 58. Johnson & Johnson Services, Inc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Johnson & Johnson Services, Inc Main Business
Table 60. Johnson & Johnson Services, Inc Latest Developments
Table 61. F. Hoffmann-La Roche AG Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 63. F. Hoffmann-La Roche AG Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. F. Hoffmann-La Roche AG Main Business
Table 65. F. Hoffmann-La Roche AG Latest Developments
Table 66. Boehringer Ingelheim International GmbH Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 67. Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 68. Boehringer Ingelheim International GmbH Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Boehringer Ingelheim International GmbH Main Business
Table 70. Boehringer Ingelheim International GmbH Latest Developments
Table 71. Abbvie Inc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 72. Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 73. Abbvie Inc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Abbvie Inc Main Business
Table 75. Abbvie Inc Latest Developments
Table 76. AstraZeneca Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 77. AstraZeneca Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 78. AstraZeneca Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Latest Developments
Table 81. Pfizer, Inc Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 82. Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 83. Pfizer, Inc Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Pfizer, Inc Main Business
Table 85. Pfizer, Inc Latest Developments
Table 86. Clovis Oncology Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 87. Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 88. Clovis Oncology Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Clovis Oncology Main Business
Table 90. Clovis Oncology Latest Developments
Table 91. Amgen Inc. Details, Company Type, Ovarian Cancer Targeted Therapy Drugs Area Served and Its Competitors
Table 92. Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Product Offered
Table 93. Amgen Inc. Ovarian Cancer Targeted Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Amgen Inc. Main Business
Table 95. Amgen Inc. Latest Developments
LIST OF FIGURES
Figure 1. Ovarian Cancer Targeted Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ovarian Cancer Targeted Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Ovarian Cancer Targeted Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Ovarian Cancer Targeted Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Ovarian Cancer Targeted Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Ovarian Cancer Targeted Therapy Drugs in Hospital Pharmacy
Figure 11. Global Ovarian Cancer Targeted Therapy Drugs Market: Hospital Pharmacy (2019-2024) & ($ millions)
Figure 12. Ovarian Cancer Targeted Therapy Drugs in Drug Stores and Retail Pharmacy
Figure 13. Global Ovarian Cancer Targeted Therapy Drugs Market: Drug Stores and Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Ovarian Cancer Targeted Therapy Drugs in Online Providers
Figure 15. Global Ovarian Cancer Targeted Therapy Drugs Market: Online Providers (2019-2024) & ($ millions)
Figure 16. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application in 2023
Figure 17. Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Player in 2023
Figure 18. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas Ovarian Cancer Targeted Therapy Drugs Value Market Share by Country in 2023
Figure 24. United States Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. China Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. India Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. France Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Ovarian Cancer Targeted Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ovarian Cancer Targeted Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Ovarian Cancer Targeted Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Ovarian Cancer Targeted Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Ovarian Cancer Targeted Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Ovarian Cancer Targeted Therapy Drugs in Hospital Pharmacy
Figure 11. Global Ovarian Cancer Targeted Therapy Drugs Market: Hospital Pharmacy (2019-2024) & ($ millions)
Figure 12. Ovarian Cancer Targeted Therapy Drugs in Drug Stores and Retail Pharmacy
Figure 13. Global Ovarian Cancer Targeted Therapy Drugs Market: Drug Stores and Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Ovarian Cancer Targeted Therapy Drugs in Online Providers
Figure 15. Global Ovarian Cancer Targeted Therapy Drugs Market: Online Providers (2019-2024) & ($ millions)
Figure 16. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application in 2023
Figure 17. Global Ovarian Cancer Targeted Therapy Drugs Revenue Market Share by Player in 2023
Figure 18. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 19. Americas Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 20. APAC Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 21. Europe Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Americas Ovarian Cancer Targeted Therapy Drugs Value Market Share by Country in 2023
Figure 24. United States Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 30. APAC Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 31. China Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. India Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. France Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Ovarian Cancer Targeted Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 54. APAC Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 55. Europe Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. United States Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Canada Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. Mexico Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Brazil Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. China Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Japan Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. Korea Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. India Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Australia Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. Germany Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. France Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. UK Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. Italy Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. Russia Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Egypt Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. South Africa Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Israel Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. Turkey Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Ovarian Cancer Targeted Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Ovarian Cancer Targeted Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
